PHARMACOKINETICS AND BIOAVAILABILITY OF INTRAVENOUS, ORAL, AND RECTAL NITRAZEPAM IN HUMANS

被引：28

作者：

JOCHEMSEN, R ^{[1
]}

HOGENDOORN, JJH ^{[1
]}

DINGEMANSE, J ^{[1
]}

HERMANS, J ^{[1
]}

BOEIJINGA, JK ^{[1
]}

BREIMER, DD ^{[1
]}

机构：

[1] LEIDEN STATE UNIV,FAC MED,DEPT MED STAT,2312 AV LEIDEN,NETHERLANDS

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1982年 / 10卷 / 03期

关键词：

D O I：

10.1007/BF01059259

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：231 / 245

页数：15

共 15 条

[1] PLASMA-LEVEL PROFILE OF NITRAZEPAM (MOGADON) FOLLOWING ORAL-ADMINISTRATION [J].

BREIMER, DD ;

BRACHT, H ;

DEBOER, AG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (06) :709-711

[2]

de Boer A G, 1978, J Chromatogr, V145, P105, DOI 10.1016/S0378-4347(00)81672-2

[3]

IGA K, 1980, INT J PHARM, V6, P43

[4]

Iisalo E, 1977, Br J Clin Pharmacol, V4, p646P

[5] INFLUENCE OF SEX, MENSTRUAL-CYCLE AND ORAL CONTRACEPTION ON THE DISPOSITION OF NITRAZEPAM [J].

JOCHEMSEN, R ;

VANDERGRAAFF, M ;

BOEIJINGA, JK ;

BREIMER, DD .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (03) :319-324

[6] HUMAN PHARMACOKINETICS OF NITRAZEPAM - EFFECT OF AGE AND DISEASES [J].

KANGAS, L ;

IISALO, E ;

KANTO, J ;

LEHTINEN, V ;

PYNNONEN, S ;

RUIKKA, I ;

SALMINEN, J ;

SILLANPAA, M ;

SYVALAHTI, E .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (03) :163-170

[7]

KANGAS L, 1979, ACTA PHARMACOL TOX, V45, P20

[8] LONG-TERM NITRAZEPAM TREATMENT IN PSYCHIATRIC OUT-PATIENTS WITH INSOMNIA [J].

KANGAS, L ;

KANTO, J ;

LEHTINEN, V ;

SALMINEN, J .

PSYCHOPHARMACOLOGY, 1979, 63 (01) :63-66

[9]

MAGNUSSEN I, 1979, ACTA PHARMACOL TOX, V45, P87

[10] PLASMA CONCENTRATION OF DIAZEPAM AND N-DESMETHYLDIAZEPAM IN CHILDREN AFTER A SINGLE RECTAL OR INTRAMUSCULAR DOSE OF DIAZEPAM [J].

MEBERG, A ;

LANGSLET, A ;

BREDESEN, JE ;

LUNDE, PKM .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (04) :273-276

← 1 2 →